Ann: DMC Completes Final Review of Phase 3 Heart Failure Trial, page-8

  1. 16,294 Posts.
    lightbulb Created with Sketch. 6193
    Yes really stepping up the communications to the market and shareholders ... I got this email this afternoon, which I haven't received before so very happy that MSB are further stepping up their marketing etc ...... add this to the twitter posts and we are becoming a whole other entity IMO




    18 December 2019

    Dear Shareholder,

    Mesoblast Limited recently lodged two announcements with the ASX, which are now available to view by clicking on the links below:

    CHF P3 Trial Accrues Sufficient Primary Endpoint Events

    DMC Completes Final Review of Phase 3 Heart Failure Trial

    All announcements are also available on our website www.mesoblast.com

    Yours faithfully,

    Charlie Harrison
    Company Secretary
    Mesoblast Limited
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.73
Change
0.025(1.47%)
Mkt cap ! $2.207B
Open High Low Value Volume
$1.68 $1.73 $1.64 $4.189M 2.480M

Buyers (Bids)

No. Vol. Price($)
2 31201 $1.72
 

Sellers (Offers)

Price($) Vol. No.
$1.73 59276 6
View Market Depth
Last trade - 16.10pm 16/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.